Company:  GALENA BIOPHARMA, INC. (GALE)
Form Type:  8-K
Filing Date:  11/18/2011 
CIK:  0001390478 
Address:  4640 SW MACADAM AVENUE
SUITE 270
 
City, State, Zip:  PORTLAND, Oregon 97239 
Telephone:  855 855 GALE 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.05  
Change: 
-0.16 (-7.24%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$242.32M
Description of Business
Galena Biopharma, Inc. (�we,� �us,� �our,� �Galena� or the �company�) is a biopharmaceutical company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care. We currently are developing innovative, peptide antigen-based �off the shelf� cancer immunotherapies for potential application to treatment of large populations of cancer survivors. Peptide vaccines have several potential clinical advantages over existing cancer treatments including excellent safety profiles, long-lasting protection through immune system activation, as well as an acceptable mode of administration (intradermal injection). In addition, there are potential commercial advantages in that these are readily and reproducibly manufactured products that could have a wide reach into the physicians� office, with no special requirements for delivery to the office or to patients.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01 Notice of Delisting or Failure to Satisfy a ...
    SIGNATURES
BROKERAGE PARTNERS